Paper40910282
How big is the medical writing industry? Why it matters.
Bernisson M and 1 other. Health Promot Int, 2025. Cited by 0 papers, by iCite.
Cite this record
ConductScience Library. How big is the medical writing industry? Why it matters. Papers, record 40910282. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/40910282
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics4
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Drug Industry | Major topic |
| Medical Writing | Major topic |
| Publishing | Major topic |
| Humans |
Source PubMed
Grants4
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| European Research Council | International | PubMed | ||
| 951393 | European Union's H2020 programme | PubMed | ||
| 435-2022-0182 | European Union's H2020 programme | PubMed | ||
| Social Sciences and Humanities Research Council | PubMed |
Source PubMed
References21
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 38737766 | Promoting opioids, a story about how to influence medical science and opinions. | Front Med (Lausanne) | 2024 | https://conductscience.org/library/papers/38737766 | PubMed |
| 2 | 21857807 | Being the ghost in the machine: a medical ghostwriter's personal view. | PLoS Med | 2011 | https://conductscience.org/library/papers/21857807 | PubMed |
| 3 | 12775615 | Evidence b(i)ased medicine--selective reporting from studies sponsored by pharmaceutical industry: review of studies in new drug applications. | BMJ | 2003 | https://conductscience.org/library/papers/12775615 | PubMed |
| 4 | 18413874 | Guest authorship and ghostwriting in publications related to rofecoxib: a case study of industry documents from rofecoxib litigation. | JAMA | 2008 | https://conductscience.org/library/papers/18413874 | PubMed |
| 5 | 30607994 | Can self-regulation deliver an ethical commercial literature? A critical reading of the "Good Publication Practice" (GPP3) guidelines for industry-financed medical journal articles. | Account Res | 2019 | https://conductscience.org/library/papers/30607994 | PubMed |
| 6 | 15297997 | Shaping the intimate: influences on the experience of everyday nerves. | Soc Stud Sci | 2004 | https://conductscience.org/library/papers/15297997 | PubMed |
| 7 | 28207928 | Industry sponsorship and research outcome. | Cochrane Database Syst Rev | 2017 | https://conductscience.org/library/papers/28207928 | PubMed |
| 8 | 22013363 | Medical ghost-writing. | Mens Sana Monogr | 2008 | https://conductscience.org/library/papers/22013363 | PubMed |
| 9 | 27176755 | The citalopram CIT-MD-18 pediatric depression trial: Deconstruction of medical ghostwriting, data mischaracterisation and academic malfeasance. | Int J Risk Saf Med | 2016 | https://conductscience.org/library/papers/27176755 | PubMed |
| 10 | 17227134 | Ghost authorship in industry-initiated randomised trials. | PLoS Med | 2007 | https://conductscience.org/library/papers/17227134 | PubMed |
| 11 | 30227485 | Corporate Integrity Agreements: What They Say About Publications, Publication Planning, Transparency, and ICMJE. | Ther Innov Regul Sci | 2013 | https://conductscience.org/library/papers/30227485 | PubMed |
| 12 | 15987332 | The corporate coauthor. | J Gen Intern Med | 2005 | https://conductscience.org/library/papers/15987332 | PubMed |
| 13 | 23135337 | The paroxetine 352 bipolar trial: A study in medical ghostwriting. | Int J Risk Saf Med | 2012 | https://conductscience.org/library/papers/23135337 | PubMed |
| 14 | 16304738 | The contract research organization and the commercialization of scientific research. | Soc Stud Sci | 2005 | https://conductscience.org/library/papers/16304738 | PubMed |
| 15 | 9676661 | Prevalence of articles with honorary authors and ghost authors in peer-reviewed medical journals. | JAMA | 1998 | https://conductscience.org/library/papers/9676661 | PubMed |
| 16 | 20838656 | The haunting of medical journals: how ghostwriting sold "HRT". | PLoS Med | 2010 | https://conductscience.org/library/papers/20838656 | PubMed |
| 17 | 17896859 | Ghost management: how much of the medical literature is shaped behind the scenes by the pharmaceutical industry? | PLoS Med | 2007 | https://conductscience.org/library/papers/17896859 | PubMed |
| 18 | 21327175 | Of sophists and spin-doctors: industry-sponsored ghostwriting and the crisis of academic medicine. | Mens Sana Monogr | 2010 | https://conductscience.org/library/papers/21327175 | PubMed |
| 19 | 19192943 | What should be done to tackle ghostwriting in the medical literature? | PLoS Med | 2009 | https://conductscience.org/library/papers/19192943 | PubMed |
| 20 | 33257869 | Key opinion leaders - a critical perspective. | Nat Rev Rheumatol | 2021 | https://conductscience.org/library/papers/33257869 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Cited by
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/40910282
GET https://conductscience.org/api/papers/v1/40910282/references?page=2